WHITE PLAINS, NEW YORK, U.S. — Bunge Limited announced on Aug. 26 that Jacqualyn A. Fouse, chief financial officer (CFO), will be leaving the company effective Sept. 24, to become CFO of Celgene Corp., a global biopharmaceutical company. Bunge has initiated a search for Fouse's replacement. Andrew J. Burke, the company's global operational excellence officer, will serve as interim CFO.
"Jackie has made many contributions to Bunge during her tenure. She spearheaded initiatives to increase efficiency and provided valuable leadership during a particularly volatile time in our markets and the global economy," said Alberto Weisser, chairman and chief executive officer, Bunge Limited. "I would like to express our appreciation and wish her success in her future endeavors. At the same time, I am pleased that Drew will serve as interim CFO. He is a highly experienced executive with strong finance and operational expertise. Given his deep knowledge of Bunge, we expect a smooth transition."
Fouse said, "I'm honored to have served as Bunge's CFO, and I am proud of what we have accomplished. Bunge has a bright future, and I wish the team all the best."
Burke, 55, joined Bunge in 2002 and has served as co-CEO, Bunge Global Agribusiness and Bunge Product Lines, and as managing director, Soy Ingredients and New Business Development. Burke acted as interim CFO from April to July 2007. Prior to joining Bunge, he was CEO of Degussa Corp., the U.S. subsidiary of the German chemical concern, where he also served as CFO and held a variety of finance and management positions.